✦ LIBER ✦

Adjuvant chemotherapy in pancreatic cancer

✍ Scribed by Simon R. Bramhall; John P. Neoptolemos

Publisher: Springer US
Year: 1997
Tongue: English
Weight: 465 KB
Volume: 21
Category: Article
ISSN: 1941-6628
DOI: 10.1007/bf02785921

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Survival benefits of adjuvant chemothera

Survival benefits of adjuvant chemotherapy with oral doxifluridine (5′-DFUR) following radiotherapy in patients with unresectable pancreatic cancer

✍ Koji Tsuruta; Astutake Okamoto; Naoto Egawa; Terumi Kamisawa; Katsuyuki Karasawa 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB

## Abstract ## Background and Objectives The combination of 5‐fluorouracil and radiotherapy is thought to be the most effective treatment for locally unresectable pancreatic carcinoma. The outcomes, however, are far from acceptable from the viewpoint of long‐term survival. We assessed the survival

Randomized study of 5-FU and ccnu in pan

Randomized study of 5-FU and ccnu in pancreatic cancer: Report of the veterans administration surgical adjuvant cancer chemotherapy study group

✍ Charles Frey; Patrick Twomey; Rubert Keehn; Daniel Elliott; George Higgins 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 413 KB 👁 2 views

Between the years 1973-1977, 152 male patients from 28 participating Veterans Hospitals with histologically proven nonresectable cancer of the pancreas were randomized in a two-arm study. The treated group was to receive combination chemotherapy with 5-FU and CCNU, and the controls were to receive n

p53 alteration is not an independent pro

p53 alteration is not an independent prognostic indicator, but affects the efficacy of adjuvant chemotherapy in human pancreatic cancer

✍ Ming Dong; Yoshinori Nio; Kunihiro Yamasawa; Tomoko Toga; Lishuang Yue; Takayuki 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB

Progress report: A randomized multicente

Progress report: A randomized multicenter European stydy comparing adjuvant radiotherapy, 6 Mo chemotherapy, and combination therapy vs No-adjuvant treatment in resectable pancreatic cancer (ESPAC-1)

✍ John P. Neoptolemos; Pat Baker; Hans Beger; Karl Link; Paolo Pederzoli; Claudio 📂 Article 📅 1997 🏛 Springer US 🌐 English ⚖ 839 KB

A randomized phase II trial of adjuvant

A randomized phase II trial of adjuvant chemotherapy with uracil/tegafur and gemcitabine versus gemcitabine alone in patients with resected pancreatic cancer

✍ Hideyuki Yoshitomi; Akira Togawa; Fumio Kimura; Hiroshi Ito; Hiroaki Shimizu; Hi 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 1 views

Quality of life after adjuvant intra-art

Quality of life after adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer : A prospective randomized controlled study

✍ Marjolein J. M. Morak; Chulja J. Pek; Erwin J. O. Kompanje; Wim C. J. Hop; Geert 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 1 views